Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Acute graft versus host disease rate,severity and response to treatment
100 days
Yes
Moshe Yeshurun, MD
Principal Investigator
Davidoff cancer center, Beilinson hospital, Rabin Medical Center
Israel: Ethics Commission
6188
NCT01385072
August 2011
April 2015
Name | Location |
---|